Bacterial DNA and related nucleic acids

Bacterial DNA and related nucleic acids, including various forms of RNA, constitute the essential genetic material and catalytic machinery required for bacterial survival, growth, and pathogenesis. These molecules facilitate the storage of hereditary information, the replication of the genome during binary fission, and the translation of genetic codes into functional proteins via the ribosome [PubMed: 11585180]. In clinical medicine, bacterial nucleic acids are primary targets for several classes of antimicrobial agents that exploit structural and enzymatic differences between prokaryotic and eukaryotic systems. For example, fluoroquinolones interfere with DNA gyrase and topoisomerase IV to prevent DNA replication, while nitroimidazoles induce lethal strand breaks in the DNA of anaerobic bacteria [StatPearls: NBK547740, PubMed: 10348827]. Additionally, specific sequences such as unmethylated CpG motifs in bacterial DNA are recognized by the host immune system as foreign, triggering inflammatory responses through pattern recognition receptors like Toll-like receptor 9 [Nature Reviews Immunology: 10.1038/nri1367]. Understanding the dynamics of these nucleic acids is vital for developing new antibiotics and diagnostic tools, such as PCR-based detection of bacterial loads and resistance markers in infected patients [NCBI: NBK557480].

Other names

Prokaryotic DNABacterial genomeBacterial RNACpG DNABacterial nucleic acids

Drugs targeting bacterial nucleic acids act by inducing direct oxidative damage and strand breaks, inhibiting topoisomerase enzymes (DNA gyrase and Topoisomerase IV) to prevent replication and transcription, or binding to RNA polymerase to block mRNA synthesis.